Self-stigma and treatment effectiveness in patients with anxiety disorders - a mediation analysis
Status PubMed-not-MEDLINE Jazyk angličtina Země Nový Zéland Médium electronic-ecollection
Typ dokumentu časopisecké články
PubMed
29416340
PubMed Central
PMC5790087
DOI
10.2147/ndt.s152208
PII: ndt-14-383
Knihovny.cz E-zdroje
- Klíčová slova
- anxiety disorders, medication, self-stigma, treatment effectiveness,
- Publikační typ
- časopisecké články MeSH
GOAL: The goal of this study was to explore the impact of self-stigma on the treatment outcomes in patients with anxiety disorders and to find possible mediators of this relationship. METHOD: Two hundred and nine patients with anxiety disorders, who were hospitalized in a psychotherapeutic department, attended the study. The average age was 39.2±12.4 years; two-thirds were women. Most of the patients used a long-term medication. The participants underwent either cognitive behavioral therapy (CBT) or short psychodynamic therapy. The selection to the psychotherapy was not randomized. All individuals completed several scales - Beck Depression Inventory, the second edition (BDI-II), Beck Anxiety Inventory (BAI), Dissociative Experience Scale (DES), Sheehan Disability Scale (SDS), subjective Clinical Global Impression (subjCGI), and The Internalized Stigma of Mental Illness Scale (ISMI). A senior psychiatrist filled out the objective CGI (objCGI). RESULTS: The patients significantly improved in the severity of anxiety (BAI), depression (BDI-II), and overall severity of the mental disorder (objCGI). The self-stigma predicted a lower change of the objCGI, but not a change of the anxiety and depressive symptoms severity. Anxiety, depressive symptoms, dissociation, and disability were assessed as possible mediators of the relationship between the self-stigma and the treatment change. None of them were significant. CONCLUSION: Self-stigma lowers the effectiveness of the combined treatment of anxiety disorders. Future research should explore other possible mediators influencing this relationship.
Zobrazit více v PubMed
Corrigan PW, Rao D. On the self-stigma of mental illness: Stages, disclosure, and strategies for change. Can J Psychiatry. 2012;57(8):464–469. PubMed PMC
Seligman ME, Abramson LY, Semmel A, von Baeyer C. Depressive attributional style. J Abnorm Psychol. 1979;88(3):242–247. PubMed
Parcesepe AM, Cabassa LJ. Public stigma of mental illness in the United States: a systematic literature review. Admin Policy Ment Health. 2013;40(5):384–399. PubMed PMC
Rüsch N, Corrigan PW, Powell K, et al. A stress-coping model of mental illness stigma: II. Emotional stress responses, coping behavior and outcome. Schizophr Res. 2009;110(1–3):65–71. PubMed PMC
Drapalski AM, Lucksted A, Perrin PB, et al. A model of internalized stigma and its effects on people with mental illness. Psychiat Serv. 2013;64:264–269. PubMed
Corrigan PW, Larson JE, Rüsch N. Self-stigma and the “why try” effect: Impact on life goals and evidence-based practices. World Psychiatry. 2009;8(2):75–81. PubMed PMC
Ociskova M, Prasko J, Kamaradova D, Grambal A, Sigmundova Z. Individual correlates of self-stigma in patients with anxiety disorders with and without comorbidities. Neuropsychiatr Dis Treat. 2015;11:1767–1779. PubMed PMC
Yanos PT, West ML, Gonzales L, Smith SM, Roe D, Lysaker PH. Change in internalized stigma and social functioning among persons diagnosed with severe mental illness. Psychiatry Res. 2012;200(2–3):1032–1034. PubMed PMC
Ociskova M, Prasko J, Latalova K, Kamaradova D, Grambal A. Psychological factors and treatment effectiveness in resistant anxiety disorders in highly comorbid inpatients. Neuropsychiatr Dis Treat. 2016;12:1539–1551. PubMed PMC
Prasko J, Grambal A, Kasalova P, et al. Impact of dissociation on treatment of depressive and anxiety spectrum disorders with and without personality disorders. Neuropsychiatr Dis Treat. 2016;12:2659–2676. PubMed PMC
Prasko J, Ociskova M, Grambal A, et al. Personality features, dissociation, self-stigma, hope, and the complex treatment of depressive disorder. Neuropsychiatr Dis Treat. 2016;12:2539–2552. PubMed PMC
Wood L, Byrne R, Morrison AP. An integrative cognitive model of internalized stigma in psychosis. Behav Cogn Psychother. 2017;45(6):545–560. PubMed
Sirey JA, Bruce ML, Alexopoulos GS, et al. Perceived stigma as a predictor of treatment discontinuation in young and older outpatients with depression. Am J Psychiatry. 2001;158(3):479–481. PubMed
Cavelti M, Kvrgic S, Beck EM, Rüsch N, Vauth R. Self-stigma and its relationship with insight, demoralization, and clinical outcome among people with schizophrenia spectrum disorders. Compr Psychiatry. 2012;53(5):468–479. PubMed
Kamaradova D, Latalova K, Prasko J, et al. Connection between self-stigma, adherence to treatment, and discontinuation of medication. Patient Prefer Adherence. 2016;10:1289–1298. PubMed PMC
Cinculova A, Kamaradova D, Ociskova M, et al. Adherence, self-stigma, and discontinuation of pharmacotherapy in anxiety disorders – Cross-sectional study. Eur Psychiatry. 2015;30(Suppl. 1):1113. PubMed
Fung KM, Tsang HW, Corrigan PW. Self-stigma of people with schizophrenia as predictor of their adherence to psychosocial treatment. Psychiatr Rehabil J. 2008;32(2):95–104. PubMed
Bandelow B, Michaelis S. Epidemiology of anxiety disorders in the 21st century. Dialogues Clin Neurosci. 2015;17(3):327–335. PubMed PMC
Lépine JP. Epidemiology, burden, and disability in depression and anxiety. J Clin Psychiatry. 2001;62(Suppl 13):4–10. PubMed
Bystritsky A. Treatment-resistant anxiety disorders. Molec Psychiatry. 2006;11(9):805–814. PubMed
Baldwin D, Woods R, Lawson R, Taylor D. Efficacy of drug treatments for generalized anxiety disorder: systematic review and meta-analysis. BMJ. 2011;342:d1199. PubMed
Van Ameringen M, Mancini C, Pipe B, Greist JH, Hollander E, Montgomery SA, et al. Optimizing treatment in social phobia: A review of treatment resistance. CNS Spectr. 2004;9(10):753–762. PubMed
Holt RL, Lydiard RB. Management of treatment-resistant panic disorder. Psychiatry (Edgemont) 2007;4(10):48–59. PubMed PMC
Prasko J, Kamaradova D, Cakirpaloglu S, et al. Predicting the therapeutic response to intensive psychotherapeutic programs in patients with neurotic spectrum disorders. Activitas Nervosa Super Rediviva. 2015;57(1–2):30–39.
Hofman SG. Cognitive factors that maintain social anxiety disorder: A comprehensive model and its treatment implications. Cogn Behav Ther. 2007;36(4):193–209. PubMed PMC
Wong QJJ, Rapee RM. The aetiology and maintenance of social anxiety disorder: A synthesis of complimentary theoretical models and formulation of a new integrated model. J Affect Disord. 2016;203:84–100. PubMed
Hettema JM, Neale MC, Kendler KS. A review and meta-analysis of the genetic epidemiology of anxiety disorders. Am J Psychiatry. 2001;158(10):1568–1578. PubMed
Lysaker PH, Roe D, Yanos PT. Toward understanding the insight paradox: Internalized stigma moderates the association between insight and social functioning, hope, and self-esteem among people with schizophrenia spectrum disorders. Schizophr Bull. 2007;33(1):192–199. PubMed PMC
Alonso J, Buron A, Bruffaerts R, et al. Association of perceived stigma and mood and anxiety disorders: results from the World Mental Health Surveys. Acta Psychiatr Scand. 2008;118(4):305–314. PubMed PMC
Lysaker PH, Yanos P, Outcalt J, Roe D. Association of stigma, self-esteem, and symptoms with concurrent and prospective assessment of social anxiety in schizophrenia. Clin Schizophr Relat Psychoses. 2010;4(1):41–48. PubMed PMC
Link BG, Struening EL, Rahav M, Phelan JC, Nuttbrock L. On stigma and its consequences: Evidence from a longitudinal study of men with dual diagnoses of mental illness and substance abuse. J Health Soc Behav. 1997;38:177–190. PubMed
International Classification of Disorders . Mental and behavioural disorders: Research diagnostic criteria. Prague: Prague Psychiatric Centre; 1996. 10th revision (Czech translation)
Sheehan DV, Lecrubier Y, Sheehan KH, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59(Suppl 20):22–33. PubMed
Guy W. ECDEU Assessment manual for psychopharmacology. Rockville: DHEW; 1976.
Kadouri A, Corruble E, Falissard B. The improved Clinical Global Impression Scale (iCGI): Development and validation in depression. BMC Psychiatry. 2007;7:7. PubMed PMC
Beck AT, Epstein N, Brown G, Steer RA. An inventory for measuring clinical anxiety: Psychometric properties. J Consult Clin Psychology. 1988;56:893–897. PubMed
De Ayala RJ, Vonderharr-Carlson DJ, Kim D. Assessing the reliability of the Beck Anxiety Inventory scores. Educ Psychol Meas. 2005;65(5):742–756.
Kamaradova D, Prasko J, Latalova K, et al. Psychometric properties of the Czech version of the Beck Anxiety Inventory – Comparison between diagnostic groups. Neuro Endocrinol Lett. 2015;36(7):706–712. PubMed
Beck AT, Steer RA, Ball R, Ranieri W. Comparison of Beck Depression Inventories-IA and II in psychiatric outpatients. J Pers Assess. 1996;67:588–597. PubMed
Storch EA, Roberti JW, Roth DA. Factor structure, concurrent validity, and internal consistency of the Beck Depression Inventory – Second Edition in a sample of college students. Depress Anxiety. 2004;19(3):187–189. PubMed
Ociskova M, Prasko J, Kupka M, et al. Psychometric evaluation of the Czech Beck Depression Inventory–II in a sample of depressed patients and healthy controls. Neuro Endocrinol Lett. 2017;38(2):98–106. PubMed
Ritsher JB, Otilingam PG, Grajales M. Internalized stigma of mental illness: Psychometric properties of a new measure. Psychiatry Res. 2003;121(1):31–49. PubMed
Ociskova M, Prasko J, Kamarádová D’, et al. Self-stigma in psychiatric patients – Standardization of the ISMI scale. Neuro Endocrinol Lett. 2014;35(7):624–632. PubMed
Bernstein EM, Putnam FW. Development, reliability, and validity of a dissociation scale. J Nerv Ment Dis. 1986;174(12):727–735. PubMed
Waller DA, Gullion CM, Petty F, Hardy BW, Murdock MV, Rush AJ. Tridimensional Personality Questionnaire and serotonin in bulimia nervosa. Psychiatry Res. 1993;48(1):9–15. PubMed
Ptacek R, Bob P, Paclt I. Skala disociativnich zkusenosti – ceska verze [Dissociative Experiences Scale – A Czech version] Ceskoslovenska psycholologie. 2006;50(3):262–272. Czech with an English abstract.
Sheehan DV, Harnett-Sheehan K, Raj BA. The measurement of disability. Int Clin Psychopharmacol. 1996;11(Suppl 3):89–95. PubMed
Leon AC, Shear MK, Portera L, Klerman GL. Assessing impairment in patients with panic disorder: the Sheehan Disability Scale. Soc Psychiatry Psychiatr Epidemiol. 1992;27(2):78–82. PubMed
Sheehan KH, Sheehan DV. Assessing treatment effects in clinical trials with the discan metric of the Sheehan Disability Scale. Int Clin Psychopharmacol. 2008;23(2):70–83. PubMed
Arbuckle R, Frye MA, Brecher M, et al. The psychometric validation of the Sheehan Disability Scale (SDS) in patients with bipolar disorder. Psychiatry Res. 2009;165(1–2):163–174. PubMed
Cohen J. Statistical power analysis for the behavioral sciences (second edition) Hillsdale: Lawrence Erlbaum Associates; 1988.
EMEA . Guideline for good clinical practice. London: EMEA; [Accessed September 15, 2017]. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500002874.pdf.
Finney SJ, DiStefano C. Non-normal and categorical data in structural equation modeling. In: Hancock GR, Mueller RD, editors. Structural Equation Modeling: A Second Course. Greenwich: Information Age Publishing; 2006. pp. 269–314.
Alonso J, Angermeyer MC, Bernert S, et al. Prevalence of mental disorders in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr Scand Suppl. 2004;(420):21–27. PubMed
Michael T, Zetsche U, Margraf J. Epidemiology of anxiety disorders. Epidemiol Psychopharmacol. 2007;6(4):136–142.
Taylor S, Abramowitz JS, McKay D. Non-adherence and non-response in the treatment of anxiety disorders. J Anxiety Disord. 2012;26(5):583–589. PubMed
Roe D, Hasson-Ohayon I, Mashiach-Eizenberg M, Derhy O, Lysaker PH, Yanos PT. Narrative Enhancement and Cognitive Therapy (NECT) effectiveness: A quasi-experimental study. J Clin Psychol. 2014;70(4):303–312. PubMed PMC
Open Science Collaboration Estimating the reproducibility of psychological science. Science. 2015;349(6251):aac4716. PubMed
Corrigan PW, Watson AC. Understanding the impact of stigma on people with mental illness. World Psychiatry. 2002;1(1):16–20. PubMed PMC